Stage IIIA Vulvar Cancer AJCC v7
3 clinical trials · Condition
◉ Watch Stage IIIA Vulvar Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma (NCT03220009) | National Cancer Institute (NCI) | 2017-11-03 |
| Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva (NCT01595061) | Gynecologic Oncology Group | 2012-07-02 |
Track Stage IIIA Vulvar Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.